106 related articles for article (PubMed ID: 22365766)
21. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes.
Gladow M; Becker C; Blankenstein T; Uckert W
J Gene Med; 2000; 2(6):409-15. PubMed ID: 11199261
[TBL] [Abstract][Full Text] [Related]
22. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
Kim S; Park EJ; Yu SS; Kim S
J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
[TBL] [Abstract][Full Text] [Related]
23. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
Pizzato M; Blair ED; Fling M; Kopf J; Tomassetti A; Weiss RA; Takeuchi Y
Gene Ther; 2001 Jul; 8(14):1088-96. PubMed ID: 11526456
[TBL] [Abstract][Full Text] [Related]
24. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
Ploss M; Berdel B; Heber R; Reuss FU
J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
[TBL] [Abstract][Full Text] [Related]
26. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
27. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
Reuss FU; Berdel B; Ploss M; Heber R
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
[TBL] [Abstract][Full Text] [Related]
28. Gene transfer vectors derived from equine infectious anemia virus.
Olsen JC
Gene Ther; 1998 Nov; 5(11):1481-7. PubMed ID: 9930301
[TBL] [Abstract][Full Text] [Related]
29. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
30. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
Uchida E; Sato K; Iwata A; Ishii-Watabe A; Mizuguchi H; Hikata M; Murata M; Yamaguchi T; Hayakawa T
Biologicals; 2004 Sep; 32(3):139-46. PubMed ID: 15536044
[TBL] [Abstract][Full Text] [Related]
31. Modular retro-vectors for transgenic and therapeutic use.
Solaiman F; Zink MA; Xu G; Grunkemeyer J; Cosgrove D; Saenz J; Hodgson CP
Mol Reprod Dev; 2000 Jun; 56(2 Suppl):309-15. PubMed ID: 10824992
[TBL] [Abstract][Full Text] [Related]
32. Development of retroviral vectors for gene transfer to airway epithelia.
Wang G; Sinn PL; McCray PB
Curr Opin Mol Ther; 2000 Oct; 2(5):497-506. PubMed ID: 11249752
[TBL] [Abstract][Full Text] [Related]
33. Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.
Jang J; Lee JT; Lee K; Kim S; Kim JY; Yoon K; Kim S
Gene Ther; 2011 Mar; 18(3):240-9. PubMed ID: 20944681
[TBL] [Abstract][Full Text] [Related]
34. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
36. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
[TBL] [Abstract][Full Text] [Related]
37. Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.
Barsov EV; Hughes SH
J Virol; 1996 Jun; 70(6):3922-9. PubMed ID: 8648729
[TBL] [Abstract][Full Text] [Related]
38. Expression of YB-1 enhances production of murine leukemia virus vectors by stabilizing genomic viral RNA.
Li W; Wang X; Gao G
Protein Cell; 2012 Dec; 3(12):943-9. PubMed ID: 23225179
[TBL] [Abstract][Full Text] [Related]
39. Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.
Steidl S; Schüle S; Mühlebach MD; Stitz J; Boller K; Cichutek K; Schweizer M
J Gen Virol; 2004 Mar; 85(Pt 3):665-678. PubMed ID: 14993652
[TBL] [Abstract][Full Text] [Related]
40. Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.
Metzl C; Mischek D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2006 Jul; 80(14):7070-8. PubMed ID: 16809312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
